Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells.


Journal

Neoplasia (New York, N.Y.)
ISSN: 1476-5586
Titre abrégé: Neoplasia
Pays: United States
ID NLM: 100886622

Informations de publication

Date de publication:
07 2019
Historique:
received: 06 03 2019
revised: 22 04 2019
accepted: 24 04 2019
pubmed: 8 6 2019
medline: 18 12 2019
entrez: 8 6 2019
Statut: ppublish

Résumé

Chromosomal aneuploidy is a defining feature of epithelial cancers. The pattern of aneuploidies is cancer-type specific. For instance, the gain of chromosome 13 occurs almost exclusively in colorectal cancer. We used microcell-mediated chromosome transfer to generate gains of chromosome 13 in the diploid human colorectal cancer cell line DLD-1. Extra copies of chromosome 13 resulted in a significant and reproducible up-regulation of transcript levels of genes on chromosome 13 (P = .0004, FDR = 0.01) and a genome-wide transcriptional deregulation in all 8 independent clones generated. Genes contained in two clusters were particularly affected: the first cluster on cytoband 13q13 contained 7 highly up-regulated genes (NBEA, MAB21L1, DCLK1, SOHLH2, CCDC169, SPG20 and CCNA1, P = .0003) in all clones. A second cluster was located on 13q32.1 and contained five upregulated genes (ABCC4, CLDN10, DZIP1, DNAJC3 and UGGT2, P = .003). One gene, RASL11A, localized on chromosome band 13q12.2, escaped the copy number-induced overexpression and was reproducibly and significantly down-regulated on the mRNA and protein level (P = .0001, FDR = 0.002). RASL11A expression levels were also lower in primary colorectal tumors as compared to matched normal mucosa (P = .0001, FDR = 0.0001. Overexpression of RASL11A increases cell proliferation and anchorage independent growth while decreasing cell migration in +13 clones. In summary, we observed a strict correlation of genomic copy number and resident gene expression levels, and aneuploidy dependent consistent genome-wide transcriptional deregulation.

Identifiants

pubmed: 31174021
pii: S1476-5586(19)30128-9
doi: 10.1016/j.neo.2019.04.009
pmc: PMC6551473
pii:
doi:

Substances chimiques

Neoplasm Proteins 0
RASL11A protein, human EC 3.6.1.-
Monomeric GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

721-729

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Références

Cancer Res. 2013 Mar 15;73(6):2003-13
pubmed: 23319804
J Gastrointest Oncol. 2015 Dec;6(6):668-75
pubmed: 26697200
Science. 2008 Oct 31;322(5902):703-9
pubmed: 18974345
Cancer Res. 2004 Oct 1;64(19):6941-9
pubmed: 15466185
Am J Pathol. 2003 Oct;163(4):1405-16
pubmed: 14507648
Sci Rep. 2016 Mar 09;6:22828
pubmed: 26956415
Nat Commun. 2016 Feb 15;7:10754
pubmed: 26876972
J Vis Exp. 2014 Oct 27;(92):e51998
pubmed: 25408172
Genes Chromosomes Cancer. 1999 Jul;25(3):195-204
pubmed: 10379865
Genes Chromosomes Cancer. 2018 Mar;57(3):140-149
pubmed: 29119627
Genes Chromosomes Cancer. 1999 Apr;24(4):306-14
pubmed: 10092128
Biochem Biophys Res Commun. 2004 Apr 9;316(3):618-27
pubmed: 15033445
Mol Syst Biol. 2012;8:608
pubmed: 22968442
Nature. 2010 Feb 18;463(7283):899-905
pubmed: 20164920
Elife. 2015 May 05;4:
pubmed: 25942454
Biochim Biophys Acta. 2012 Jul;1819(7):784-93
pubmed: 22426433
Int J Cancer. 2011 Mar 1;128(5):1069-79
pubmed: 20473941
Am J Pathol. 2012 Nov;181(5):1807-22
pubmed: 23062488
Nat Genet. 2018 Oct;50(10):1375-1380
pubmed: 30224643
Science. 2007 Aug 17;317(5840):916-24
pubmed: 17702937
Environ Mol Mutagen. 2009 Oct;50(8):593-601
pubmed: 19739242
EMBO J. 2010 Apr 7;29(7):1215-24
pubmed: 20168301

Auteurs

Darawalee Wangsa (D)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Rüdiger Braun (R)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Christina H Stuelten (CH)

Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Markus Brown (M)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Kerry M Bauer (KM)

Department of Chemistry and Biochemistry and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.

Georg Emons (G)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Leigh A Weston (LA)

Department of Chemistry and Biochemistry and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.

Yue Hu (Y)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Howard H Yang (HH)

High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Maria Vila-Casadesús (M)

Laboratory of Gastrointestinal and Pancreatic Oncology, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic of Barcelona, CIBERehd, Barcelona, Spain.

Maxwell P Lee (MP)

High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Philip Brauer (P)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Lidia Warner (L)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Madhvi Upender (M)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Amanda B Hummon (AB)

Department of Chemistry and Biochemistry and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH.

Jordi Camps (J)

Laboratory of Gastrointestinal and Pancreatic Oncology, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic of Barcelona, CIBERehd, Barcelona, Spain. Electronic address: jcamps@clinic.ub.es.

Thomas Ried (T)

Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: riedt@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH